NHS National Framework for Etravirine 200mg tablets, Raltegravir 400mg tablets, Ritonavir 100mg tablets
NHS England is establishing a national framework to supply three antiretroviral tablets: Etravirine 200mg, Raltegravir 400mg, and Ritonavir 100mg. The framework runs for 12 months from November 2026, split into two lots covering different NHS regions.
- Closed1 July 2026
- Value£5.4m
- Per lot£2.7m across 2 lots
- BuyerNHS England
- CategoryHealth & medical
- RegionUK-wide
You'll want to look if you are a licensed pharmaceutical wholesaler or manufacturer able to supply antiretroviral medications to NHS regions
Might not suit a small firm
- it needs coverage across the whole UK
Possible incumbent
Mercury Pharmaceuticals Limited has won several recent NHS pharmaceutical frameworks including Golimumab, Generics Housekeeping, and Omalizumab. Inferred from prior awards to this buyer, not confirmed.